Lobbying & Influence

Work on Capitol Hill? Enjoy free access.

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

By Kate Ackley
Roll Call Staff
July 15, 2009, Midnight

A highly targeted lobbying and advertising campaign by the biotechnology and pharmaceutical industries paid off this week when a Senate panel writing health care reform legislation swung their way on the issue of biologic drugs.

Take It Off
Study: Most Tariff Bills Would Count as ‘Earmarks’
Senate Ethics Panel Admonishes Tom Coburn Over Contact With Ensign Aide
Hill Vet Smokes BBQ Competitors
The Sexy Real Estate Edition
Eric Cantor Announces GOP Summer Agenda
Liberals Balk at Nancy Pelosi Tax Proposal

Slideshow |

May 24, 2012

Sen. Scott Brown arrives in the Capitol via the Senate subway for votes on the Food and Drug Administration reauthorization bill on Thursday.

See More Multimedia

Email Newsletter Sign-Up

Breaking News Alerts
Morning and Afternoon Headlines
Heard on the Hill Updates

Follow Roll Call:

Defense Sequester Policy Briefing

Nobody seems to like the automatic Pentagon spending cuts set for January, but there is little Congressional agreement on an alternative.

Lobbying & Influence

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

Slideshow |

Email Newsletter Sign-Up

Follow Roll Call:

Defense Sequester Policy Briefing

SIGN IN

SUBSCRIBE

Lobbying & Influence

An Ad Blitz That Really Worked?

Biotech Industry Gets a Big Win on Biologics

More News

Slideshow |

Email Newsletter Sign-Up

Follow Roll Call:

Defense Sequester Policy Briefing

SIGN IN

SUBSCRIBE